Stryker (SYK) DIvidends Date & History

Key Takeaways

• Stryker Corporation (SYK) offers a current dividend yield of approximately 1.07% with an annual payout of $3.52 per share.
• The company pays dividends quarterly at $0.88 per share.
• Stryker has raised its dividend for more than 30 consecutive years, establishing it as a reliable dividend growth stock.
• The payout ratio stands near 40%, indicating strong earnings coverage and sustainability.
• Free cash flow provides ample coverage for dividend payments alongside operational needs.
• The dividend profile appeals primarily to long-term growth-oriented investors rather than high-income seekers.

Dividend Overview

Stryker Corporation (SYK) maintains a conservative dividend policy focused on consistent annual increases supported by robust earnings and cash generation. The current forward annual dividend totals $3.52 per share, paid quarterly at $0.88 per share, resulting in a yield of about 1.07%. This modest yield positions Stryker as a dividend growth stock rather than a high-yield income vehicle. The company has demonstrated a commitment to returning capital to shareholders through predictable quarterly distributions while retaining sufficient earnings for reinvestment in its medical technology businesses.

Dividend History and Growth

Stryker has increased its dividend annually for more than three decades, reflecting a long-term strategy of measured growth. Recent quarterly dividends have risen steadily, with the latest increase bringing the payment to $0.88 per share. Over the past five years, annualized dividend growth has averaged around 7-8%, supported by consistent revenue expansion in orthopedics, medical and surgical equipment, and neurotechnology. The company has never cut its dividend, maintaining an unbroken streak of increases that underscores disciplined capital allocation and financial resilience.

Dividend Sustainability and Payout Ratio

The dividend appears highly sustainable. Stryker’s payout ratio of approximately 40% leaves substantial room for earnings retention and future increases. This level is well below thresholds that typically signal risk. Earnings per share comfortably cover the annual dividend, while free cash flow provides additional coverage, with estimates around 30% of cash flow allocated to dividends. Manageable debt levels and strong operating margins further support the company’s ability to maintain and grow payments without straining its balance sheet.

Dividend Compared to Industry Peers

Within the healthcare equipment and supplies sector, Stryker’s dividend yield of roughly 1.07% aligns with the modest profile common among growth-focused medtech peers. Many competitors emphasize reinvestment over high payouts, resulting in similar or lower yields. Stryker distinguishes itself through its extended dividend growth streak and balanced approach, offering investors a combination of income stability and capital appreciation potential that compares favorably to sector averages.

AI Screener

Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify dividend stocks, income-focused investments, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore the AI Screener to discover additional opportunities.

Is This Stock Attractive for Dividend Investors?

Stryker Corporation (SYK) suits long-term dividend growth investors who prioritize consistent annual increases and financial stability over high current yields. Its low payout ratio and strong free cash flow coverage make it appropriate for conservative portfolios seeking sustainable income that can compound over time. Income-focused investors may find the yield modest compared to higher-yielding sectors, while growth-oriented dividend investors can appreciate the combination of dividend expansion and exposure to the expanding medical technology market. The stock offers a balanced profile for those building diversified income streams with an emphasis on capital preservation and gradual payout growth.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations